Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Venous Thrombosis

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 88 articles: HTML format

Single Articles

August 2025
1. PFEFERMAN MB, Rashedi S, Lip GYH, Weber C, et al
   Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications.
   Thromb Haemost. 2025 Aug 22. doi: 10.1055/a-2674-5114.
   PubMed     Abstract available
   
   
   
2. LANGHOLM C, Eide NH, Hveem K, van Es N, et al
   Risk of cancer in the short- and long-term after incident venous thromboembolism - the HUNT and Tromso studies.
   Thromb Haemost. 2025 Aug 11. doi: 10.1055/a-2679-6152.
   PubMed     Abstract available
   
   
   July 2025
3. GLISE SANDBLAD K, Svennerholm K, Philipson J, Roupe M, et al
   Time trends in cause-specific mortality in patients with pulmonary embolism aged 50 years and older.
   Thromb Haemost. 2025 Jul 29. doi: 10.1055/a-2668-5296.
   PubMed     Abstract available
   
   
   
4. CASSIANNI CE, McBane RD, Vlazny DT, Hodge DO, et al
   Venous Thromboembolism Outcomes Among Cancer and Non-cancer Patients Managed with Patient-centric Guideline-driven Protocol.
   Thromb Haemost. 2025 Jul 25. doi: 10.1055/a-2653-6161.
   PubMed     Abstract available
   
   
   
5. YANG D, Deng J, Huang S, He H, et al
   Risk factors and outcomes of subsegmental versus more central pulmonary embolism in patients with lung cancer.
   Thromb Haemost. 2025 Jul 21. doi: 10.1055/a-2661-2326.
   PubMed     Abstract available
   
   
   
6. MAI V, Jimenez D, Fergusson D, Sanchez O, et al
   Derivation and Validation of a COPD-specific Pulmonary Embolism Diagnostic Strategy.
   Thromb Haemost. 2025 Jul 10. doi: 10.1055/a-2645-3594.
   PubMed     Abstract available
   
   
   
7. MAUGE L, Madar H, Carre J, Fiore M, et al
   How to manage venous thromboembolism risk during pregnancy in patients with inherited antithrombin deficiency?
   Thromb Haemost. 2025 Jul 8. doi: 10.1055/a-2650-7959.
   PubMed     Abstract available
   
   
   June 2025
8. TAO Y, Chen H, Dong C, Zhang J, et al
   Performance of Bleeding Risk Scores for Major Bleeding in Anticoagulated Patients with Pulmonary Embolism: Insights from the CURES Registry-2.
   Thromb Haemost. 2025 Jun 24. doi: 10.1055/a-2642-0241.
   PubMed     Abstract available
   
   
   
9. PITITTO GN, Maraziti G, Squizzato A, Becattini C, et al
   Direct oral anticoagulants for prevention of venous thromboembolism after cancer-related surgery: systematic review and network meta-analysis.
   Thromb Haemost. 2025 Jun 5. doi: 10.1055/a-2628-3967.
   PubMed     Abstract available
   
   
   
10. VEDOVATI MC, Talerico R, Sacco C, Mazzetti M, et al
    Major Bleeding Risk Assessment in Patients with Cancer-Associated Venous Thromboembolism Treated with DOACs: Data from a Multicenter Cohort.
    Thromb Haemost. 2025 Jun 3. doi: 10.1055/a-2605-9015.
    PubMed     Abstract available
    
    
    May 2025
11. TAFUR A, Brenner B, Demelo-Rodriguez P, Guirado Torrecillas L, et al
    Geographic and Racial Variation in Outcomes of Acute Venous Thromboembolism: Insights from the RIETE Registry.
    Thromb Haemost. 2025 May 19. doi: 10.1055/a-2615-4591.
    PubMed     Abstract available
    
    
    
12. GMEINER J, Kaiser R, Fischer J, Kraechan A, et al
    Thromboembolic risk among patients on dual antiplatelet therapy with or without heparin thromboprophylaxis.
    Thromb Haemost. 2025 May 19. doi: 10.1055/a-2615-4785.
    PubMed     Abstract available
    
    
    
13. MARZO C, Solanich T, Tassies D, Pina E, et al
    Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations.
    Thromb Haemost. 2025 May 13. doi: 10.1055/a-2595-1811.
    PubMed     Abstract available
    
    
    
14. LUNDBECH M, Krag AE, Iversen LH, Brandsborg B, et al
    Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Surgery.
    Thromb Haemost. 2025;125:460-469.
    PubMed     Abstract available
    
    
    April 2025
15. YAN X, Huang W, Chen Y
    Serum MPO-DNA for Predicting the Risk of Venous Thromboembolism and the Effect of Statins in Patients with Spontaneous Intracerebral Hemorrhage.
    Thromb Haemost. 2025 Apr 28. doi: 10.1055/a-2595-1927.
    PubMed     Abstract available
    
    
    
16. BIRRENKOTT DA, Kabrhel C
    The Plasma Proteome and Risk of Future Venous Thromboembolism-Results from the HUNT Study in Thrombosis and Haemostasis.
    Thromb Haemost. 2025 Apr 25. doi: 10.1055/a-2575-3388.
    PubMed    
    
    
    
17. LEKNESSUND OGR, Hansen JB, Braekkan SK
    Resting heart rate and risk of incident venous thromboembolism - the Tromso study.
    Thromb Haemost. 2025 Apr 24. doi: 10.1055/a-2593-1679.
    PubMed     Abstract available
    
    
    March 2025
18. LAROUCHE A, Dollo V, Mercier G, Singbo N, et al
    Impact of Obesity and Overweight on Heparin Dosing and Clinical Outcomes in Pediatric Patients with Venous Thromboembolism.
    Thromb Haemost. 2025 Mar 24. doi: 10.1055/a-2544-6183.
    PubMed     Abstract available
    
    
    February 2025
19. JANATA K, Lipa AJ, Merrelaar A, Merrelaar M, et al
    Enhancing Pulmonary Embolism Risk Stratification: The National Early Warning Score and Its Integration into the ESC Classification.
    Thromb Haemost. 2025 Feb 24. doi: 10.1055/a-2544-3626.
    PubMed     Abstract available
    
    
    January 2025
20. SOLER E, Roldan V, Marin F
    Stress, Partner Violence, and Coagulopathy: Unmasking New Triggers for Venous Thromboembolism.
    Thromb Haemost. 2025 Jan 27. doi: 10.1055/a-2520-8725.
    PubMed     Abstract available
    
    
    
21. HOFMANN E, Stalder O, Mean M, Rodondi N, et al
    Anemia and Prognosis in Patients with Acute Venous Thromboembolism.
    Thromb Haemost. 2025 Jan 27. doi: 10.1055/a-2510-6301.
    PubMed     Abstract available
    
    
    
22. KEMPERS E, Visser C, Geijteman E, Goedegebuur J, et al
    Discontinuation of anticoagulants and occurrence of bleeding and thromboembolic events in vitamin K antagonist users with a life-limiting disease.
    Thromb Haemost. 2025 Jan 24. doi: 10.1055/a-2524-5334.
    PubMed     Abstract available
    
    
    
23. AGNELLI G, Hoffmann U, Hainaut P, Gaine S, et al
    Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe.
    Thromb Haemost. 2025 Jan 16. doi: 10.1055/a-2497-4089.
    PubMed     Abstract available
    
    
    
24. KONSTANTINIDES S, Christodoulou K, Mohr K, Uphaus T, et al
    Hospital Costs of Intracranial Haemorrhage in Patients with Acute Pulmonary Embolism: Possible Implications for Emerging Therapies.
    Thromb Haemost. 2025 Jan 8. doi: 10.1055/a-2511-4599.
    PubMed     Abstract available
    
    
    December 2024
25. MOHR K, Neusius T, Barco S, Konstantinides S, et al
    Socio-Economic Burden of Pulmonary Embolism in Europe: Shifting Priorities and Challenges for Novel Reperfusion Strategies.
    Thromb Haemost. 2024 Dec 19. doi: 10.1055/a-2505-8711.
    PubMed     Abstract available
    
    
    
26. BITSADZE V, Nikolaeva MG, Mousty E, Khizroeva J, et al
    Venous Thromboembolism at Low Risk of Recurrence in Young Women: Stress and Violence Associated with Recurrence. An International Case-Control Study.
    Thromb Haemost. 2024 Dec 18. doi: 10.1055/a-2484-0923.
    PubMed     Abstract available
    
    
    
27. GUAN Y, Gan Z, Li S, Cao X, et al
    C-reactive protein, genetic susceptibility, and the long-term risk of venous thromboembolism in patients with past cancer.
    Thromb Haemost. 2024 Dec 3. doi: 10.1055/a-2495-1350.
    PubMed     Abstract available
    
    
    November 2024
28. BRAEKKAN SK, Onsaker AL, Nost TH, Tang W, et al
    The plasma proteome and risk of future venous thromboembolism - results from the HUNT study.
    Thromb Haemost. 2024 Nov 25. doi: 10.1055/a-2484-0836.
    PubMed     Abstract available
    
    
    
29. BARBA R
    Are More Patients with Thromboembolic Disease Dying Now Than Before?
    Thromb Haemost. 2024 Nov 11. doi: 10.1055/a-2436-4669.
    PubMed    
    
    
    
30. GRANDONE E, Mastroianno M, Pacilli G, Colaizzo D, et al
    Blood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study).
    Thromb Haemost. 2024 Nov 6. doi: 10.1055/a-2461-6822.
    PubMed     Abstract available
    
    
    
31. XIAN W, Tao Y, You C, Sun R, et al
    Brisk walking pace offsets venous thromboembolism risk equivalent to established monogenic mutations.
    Thromb Haemost. 2024 Nov 5. doi: 10.1055/a-2461-3349.
    PubMed     Abstract available
    
    
    October 2024
32. LYU Y, Li H, Liu X, Zhang X, et al
    Estimated GFR Decline is Causally Associated with Acute Pulmonary Embolism: A Nested Case-Control and Mendelian Randomization Study.
    Thromb Haemost. 2024 Oct 14. doi: 10.1055/a-2439-5200.
    PubMed     Abstract available
    
    
    
33. RANALLI P, Ten Cate H
    Venous Thromboembolism Prophylaxis after hematopoietic cell transplantation: still a challenge for haematologists and haemostasiologists.
    Thromb Haemost. 2024 Oct 4. doi: 10.1055/a-2434-5010.
    PubMed     Abstract available
    
    
    
34. DU HC, Zheng YF, Shen MQ, Deng BY, et al
    Reply to "Commentary: 'No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study' ".
    Thromb Haemost. 2024 Oct 3. doi: 10.1055/s-0044-1791679.
    PubMed    
    
    
    September 2024
35. BIONDI F, Alberti M, Montemaggi E, D'Alleva A, et al
    Not just CTEPH: a narrative review on the spectrum approach to post pulmonary embolism conditions.
    Thromb Haemost. 2024 Sep 19. doi: 10.1055/a-2418-7895.
    PubMed     Abstract available
    
    
    
36. LANTING V, Takada T, Bosch F, Marshall A, et al
    Risk of recurrent venous thromboembolism in patients with cancer: an individual patient data meta-analysis and development of a prediction model.
    Thromb Haemost. 2024 Sep 19. doi: 10.1055/a-2418-3960.
    PubMed     Abstract available
    
    
    
37. DE CORTE P, Milhoranca I, Mechsner S, Oberg SA, et al
    Unravelling the causal relationship between endometriosis and the risk for developing venous thromboembolism: a pooled analysis.
    Thromb Haemost. 2024 Sep 2. doi: 10.1055/a-2407-9498.
    PubMed     Abstract available
    
    
    
38. DOLDI F, Gessler N, Anwar O, Kahle AK, et al
    In-Hospital Pulmonary Arterial Embolism after Catheter Ablation of Over 45,000 Cardiac Arrhythmias: Individualized Case Analysis of Multicentric Data.
    Thromb Haemost. 2024;124:861-869.
    PubMed     Abstract available
    
    
    August 2024
39. GLISE SANDBLAD K, Svensson CJ, Svennerholm K, Philipson J, et al
    Time trends and excess mortality compared to population controls after a first-time pulmonary embolism or deep vein thrombosis.
    Thromb Haemost. 2024 Aug 23. doi: 10.1055/a-2402-6192.
    PubMed     Abstract available
    
    
    
40. KAPTEIJN MY, Bakker N, Koekkoek JAF, Versteeg HH, et al
    Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications.
    Thromb Haemost. 2024 Aug 21. doi: 10.1055/s-0044-1789592.
    PubMed     Abstract available
    
    
    
41. KONSTANTINIDES SV
    Shifting Priorities in the Prevention of Venous Thromboembolism: Time to Focus on Overall Cardiovascular Health.
    Thromb Haemost. 2024 Aug 12. doi: 10.1055/s-0044-1788926.
    PubMed    
    
    
    
42. PASTORI D, Palareti G
    Open Issues in the Choice and Management of Direct Oral Anticoagulants in Patients with Cancer-Related Venous Thromboembolism.
    Thromb Haemost. 2024 Aug 6. doi: 10.1055/s-0044-1788997.
    PubMed    
    
    
    
43. PASTORI D, Sciacqua A
    Educational Attainment, Obesity, and Venous Thromboembolism. Is Only Matter of Weight?
    Thromb Haemost. 2024 Aug 1. doi: 10.1055/s-0044-1788904.
    PubMed    
    
    
    July 2024
44. MUJOVIC N, Potpara TS
    Pulmonary Thromboembolism After Catheter Ablation of Cardiac Arrhythmias.
    Thromb Haemost. 2024 Jul 16. doi: 10.1055/a-2366-7245.
    PubMed     Abstract available
    
    
    
45. GRANAT LM, Li H, Ondeck M, Osantowski B, et al
    Venous Thromboembolism Post-Allogeneic Hematopoietic Cell Transplant: Risk Factors, Incidence and Outcomes.
    Thromb Haemost. 2024 Jul 15. doi: 10.1055/a-2365-8883.
    PubMed     Abstract available
    
    
    June 2024
46. LIU J, Zhang Y, Zeng B
    Commentary: "No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study".
    Thromb Haemost. 2024 Jun 6. doi: 10.1055/s-0044-1787653.
    PubMed    
    
    
    May 2024
47. GORAYA SR, O'Hare C, Grace KA, Schaeffer WJ, et al
    Optimizing Use of High-Sensitivity Troponin for Risk-Stratification of Acute Pulmonary Embolism.
    Thromb Haemost. 2024 May 24. doi: 10.1055/s-0044-1786820.
    PubMed     Abstract available
    
    
    
48. ROY DC, Wang TF, Lun R, Zahrai A, et al
    Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2024 May 20. doi: 10.1055/a-2330-1371.
    PubMed     Abstract available
    
    
    
49. XIANG H, Liu M, Zhou C, Huang Y, et al
    Tea Consumption, Milk or Sweeteners Addition, Genetic Variation in Caffeine Metabolism, and Incident Venous Thromboembolism.
    Thromb Haemost. 2024 May 10. doi: 10.1055/s-0044-1786819.
    PubMed     Abstract available
    
    
    
50. DU HC, Deng BY
    Obesity-Related Traits Mediate the Effects of Educational Attainment on the Risk of Varicose Veins, Venous Thromboembolism, and Phlebitis.
    Thromb Haemost. 2024 May 10. doi: 10.1055/s-0044-1786970.
    PubMed     Abstract available
    
    
    
51. NYGREN D, Torisson G, Happonen L, Mellhammar L, et al
    Proteomic Characterization of Plasma in Lemierre's Syndrome.
    Thromb Haemost. 2024;124:432-440.
    PubMed     Abstract available
    
    
    April 2024
52. SUETA D, Yamashita Y, Morimoto T, Chatani R, et al
    Edoxaban, Rivaroxaban or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.
    Thromb Haemost. 2024 Apr 29. doi: 10.1055/a-2316-5269.
    PubMed     Abstract available
    
    
    
53. WANG Y, Hu X, Wang X, Li L, et al
    Exploring the Two-Way Link Between Migraines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
    Thromb Haemost. 2024 Apr 24. doi: 10.1055/a-2313-0311.
    PubMed     Abstract available
    
    
    
54. HUANG Z, Zheng Z, Pang L, Fu K, et al
    The Association between Obstructive Sleep Apnea and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
    Thromb Haemost. 2024 Apr 17. doi: 10.1055/a-2308-2290.
    PubMed     Abstract available
    
    
    
55. CHOI D, Froess JD, Lawler PR, Neal MD, et al
    Whole Blood Viscosity and Thromboembolic Events in Hospitalized Patients with COVID-19: Post hoc Analysis of the ATTACC/ACTIV-4a Trial.
    Thromb Haemost. 2024 Apr 16. doi: 10.1055/s-0044-1786030.
    PubMed    
    
    
    
56. LIANG B, Zha L, Peng B, Chen Q, et al
    Association of Cardiovascular Health with the Incidence of Venous Thromboembolism: A Prospective Study of 275,149 Participants from the UK Biobank.
    Thromb Haemost. 2024 Apr 12. doi: 10.1055/a-2305-6631.
    PubMed     Abstract available
    
    
    
57. DANILATOU V, Dimopoulos D, Kostoulas T, Douketis J, et al
    Machine learning-based predictive models for patients with venous thromboembolism: A Systematic Review.
    Thromb Haemost. 2024 Apr 4. doi: 10.1055/a-2299-4758.
    PubMed     Abstract available
    
    
    February 2024
58. DU HC, Zheng YF, Shen MQ, Deng BY, et al
    No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study.
    Thromb Haemost. 2024 Feb 22. doi: 10.1055/s-0044-1781425.
    PubMed     Abstract available
    
    
    
59. YU J, Wang T, Zhang X, Chen Q, et al
    Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding.
    Thromb Haemost. 2024;124:108-121.
    PubMed     Abstract available
    
    
    January 2024
60. COHEN AT, Creeper KJ, Alikhan R, Er C, et al
    Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer.
    Thromb Haemost. 2024 Jan 9. doi: 10.1055/s-0043-1778642.
    PubMed     Abstract available
    
    
    December 2023
61. HU T, Su P, Yang F, Ying J, et al
    Circulating Cytokines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
    Thromb Haemost. 2023 Dec 18. doi: 10.1055/s-0043-1777351.
    PubMed     Abstract available
    
    
    
62. STEINER D, Horvath-Puho E, Jorgensen H, Laugesen K, et al
    Risk of depression after venous thromboembolism in patients with hematological cancer: A population-based cohort study.
    Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5428.
    PubMed     Abstract available
    
    
    
63. UJUETA F
    Dietary manganese and the incidence of venous thromboembolism: Evidence for minerals and vitamins and comorbidities linked to venous thromboembolism.
    Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5513.
    PubMed     Abstract available
    
    
    November 2023
64. HUANG Y, Zhang Y, Yang S, Xiang H, et al
    Association and pathways between dietary manganese intake and incident venous thromboembolism.
    Thromb Haemost. 2023 Nov 20. doi: 10.1055/a-2213-8939.
    PubMed     Abstract available
    
    
    October 2023
65. SIGUENZA P, Lopez Nunez JJ, Falga Tirado C, Gomez-Cuervo C, et al
    Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency.
    Thromb Haemost. 2023 Oct 13. doi: 10.1055/a-2191-7510.
    PubMed     Abstract available
    
    
    
66. DIX C, Moloney M, Tran H, McFayden J, et al
    Venous thromboembolism and estrogen-containing gender-affirming hormone therapy.
    Thromb Haemost. 2023 Oct 10. doi: 10.1055/a-2188-8898.
    PubMed     Abstract available
    
    
    
67. HUSSAINI P, Larsen TL, Ghanima W, Dahm AEA, et al
    Risk factors for bleeding in cancer patients treated with conventional dose followed by low dose apixaban for venous thromboembolism.
    Thromb Haemost. 2023 Oct 10. doi: 10.1055/a-2188-8773.
    PubMed     Abstract available
    
    
    
68. MARTIN KA, Zakai NA
    Venous Thromboembolism and Obesity: Moving Toward a Better Understanding of the Population-Attributable Risk.
    Thromb Haemost. 2023 Oct 9. doi: 10.1055/s-0043-1776010.
    PubMed    
    
    
    
69. GOLDHABER SZ
    Obesity and Pulmonary Embolism: Can we Dismantle the "Obesity Paradox".
    Thromb Haemost. 2023 Oct 6. doi: 10.1055/a-2187-0966.
    PubMed     Abstract available
    
    
    September 2023
70. ROLDAN V, Soler-Espejo E, Marin F
    Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved.
    Thromb Haemost. 2023 Sep 11. doi: 10.1055/s-0043-1775582.
    PubMed    
    
    
    August 2023
71. KONSTANTINIDES S
    Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does it Mean for Clinical Practice?
    Thromb Haemost. 2023 Aug 11. doi: 10.1055/a-2152-4762.
    PubMed     Abstract available
    
    
    
72. FRISCHMUTH T, Tondel BG, Braekkan SK, Hansen JB, et al
    The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromso Study.
    Thromb Haemost. 2023 Aug 7. doi: 10.1055/s-0043-1772212.
    PubMed     Abstract available
    
    
    
73. COHEN AT, Wallenhorst C, Choudhuri S, Nassar A, et al
    A novel risk prediction score for clinically significant bleeding in patients anticoagulated for venous thromboembolism with active cancer.
    Thromb Haemost. 2023 Aug 1. doi: 10.1055/a-2145-7238.
    PubMed     Abstract available
    
    
    July 2023
74. CHAN N, Germini F
    Patterns and persistence of anticoagulant use in the treatment of venous thromboembolism: insights from South Korea.
    Thromb Haemost. 2023 Jul 18. doi: 10.1055/a-2131-7066.
    PubMed     Abstract available
    
    
    
75. CHAN N, Xu K
    Risk factors for venous thromboembolism in women of childbearing age.
    Thromb Haemost. 2023 Jul 7. doi: 10.1055/a-2125-3290.
    PubMed     Abstract available
    
    
    
76. QIAO L, Yao Y, Wu D, Xu R, et al
    The validation and modification of the Caprini risk assessment model (RAM) for evaluating venous thromboembolism (VTE) after joint arthroplasty.
    Thromb Haemost. 2023 Jul 4. doi: 10.1055/a-2122-7780.
    PubMed     Abstract available
    
    
    
77. KHORANA AA
    Immune Checkpoint Inhibitors And Venous Thromboembolism: The More Things Change....
    Thromb Haemost. 2023 Jul 3. doi: 10.1055/a-2121-9679.
    PubMed     Abstract available
    
    
    June 2023
78. GAUGLER JO, Righini M, Robert-Ebadi H, Sanchez O, et al
    Obesity as a Predictor for Pulmonary Embolism and Performance of the Age-Adjusted D-Dimer Strategy in Obese Patients with Suspected Pulmonary Embolism.
    Thromb Haemost. 2023 Jun 12. doi: 10.1055/s-0043-57018.
    PubMed     Abstract available
    
    
    
79. YOON D, Jeong HE, Choi S, Shin JY, et al
    Dynamic Patterns and Persistence of Anticoagulation Therapy in Patients with Venous Thromboembolism in South Korea: A Nationwide Cohort Study.
    Thromb Haemost. 2023 Jun 7. doi: 10.1055/a-2107-0815.
    PubMed     Abstract available
    
    
    
80. TSAI CT, Chao TF
    Incidence and Risk Factors for Pregnancy-Associated Venous Thromboembolism: Are There Differences between East and West?
    Thromb Haemost. 2023 Jun 5. doi: 10.1055/s-0043-1769736.
    PubMed    
    
    
    
81. GRANDONE E, Antonucci E, Colaizzo D, De Laurenzo A, et al
    Venous thromboembolism in women of childbearing age: insights from the START registry.
    Thromb Haemost. 2023 Jun 1. doi: 10.1055/s-0043-1769592.
    PubMed     Abstract available
    
    
    May 2023
82. LE SEVE JD, Guedon AF, Bordenave S, Agard C, et al
    Risk Factors of Venous Thromboembolic Disease in Cancer Patients Treated with Immune Checkpoint Inhibitor.
    Thromb Haemost. 2023 May 31. doi: 10.1055/s-0043-1769609.
    PubMed     Abstract available
    
    
    
83. MILLING TJ
    The Hard Bargain of Anticoagulation after Intracranial Haemorrhage, in the setting of Venous Thromboembolism: Between a rock and a hard place.
    Thromb Haemost. 2023 May 22. doi: 10.1055/a-2097-0775.
    PubMed     Abstract available
    
    
    
84. GIANNIS D, Goldin M, Rahman H, Sison CP, et al
    Risk factors for post-discharge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities.
    Thromb Haemost. 2023 May 5. doi: 10.1055/a-2087-3003.
    PubMed     Abstract available
    
    
    
85. XU K, Chan NC
    Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?
    Thromb Haemost. 2023;123:487-489.
    PubMed    
    
    
    April 2023
86. JOHNSEN SP, Jensen M, Munster AB, Frost L, et al
    Small-area analysis of treatment and clinical outcomes in patients with venous thromboembolism in Denmark: a nationwide cohort study.
    Thromb Haemost. 2023 Apr 13. doi: 10.1055/a-2073-4336.
    PubMed     Abstract available
    
    
    
87. GORMAN J, Candeloro M, Schulman S
    Anticoagulant management and outcomes in non-traumatic intracranial hemorrhage complicated by venous thromboembolism: a retrospective chart review.
    Thromb Haemost. 2023 Apr 4. doi: 10.1055/a-2068-6464.
    PubMed     Abstract available
    
    
    March 2023
88. KONSTANTINIDES S
    Modern lung scintigraphy techniques for optimising the diagnosis of pulmonary embolism: Great expectations, still waiting to be met.
    Thromb Haemost. 2023 Mar 19. doi: 10.1055/a-2057-8672.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge.